We are live on ! Find out more
MD icon

Pediatrix Medical

224 hedge funds and large institutions have $1.98B invested in Pediatrix Medical in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 71 increasing their positions, 90 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 13

82% more call options, than puts

Call options by funds: $1.29M | Put options by funds: $711K

10% more funds holding

Funds holding: 204224 (+20)

0.01% more ownership

Funds ownership: 96.93%96.93% (+0.01%)

13% less capital invested

Capital invested by funds: $2.28B → $1.98B (-$294M)

21% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 90

Holders
224
Holders Change
+20
Holders Change %
+9.8%
% of All Funds
3.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
71
Reduced
90
Closed
13
Calls
$1.29M
Puts
$711K
Net Calls
+$582K
Net Calls Change
+$5.05M
Name Holding Trade Value Shares
Change
Change in
Stake
Zurich Cantonal Bank
151
Zurich Cantonal Bank
Switzerland
$272K +$50.5K +2,063 +22%
PA
152
Profund Advisors
Maryland
$271K +$55K +2,247 +24%
Truist Financial
153
Truist Financial
North Carolina
$262K +$41.2K +1,683 +18%
RA
154
Royce & Associates
New York
$260K -$440K -17,985 -62%
JMPWA
155
JP Morgan Private Wealth Advisors
California
$242K -$1.86K -76 -0.7%
ACM
156
AlphaCrest Capital Management
New York
$242K +$253K +10,318 New
CIBC Asset Management
157
CIBC Asset Management
Ontario, Canada
$241K
FIM
158
Freedom Investment Management
Connecticut
$221K +$3.84K +157 +2%
Ohio Public Employees Retirement System (OPERS)
159
Ohio Public Employees Retirement System (OPERS)
Ohio
$214K -$11.4K -465 -5%
Mitsubishi UFJ Trust & Banking
160
Mitsubishi UFJ Trust & Banking
Japan
$210K -$78.3K -3,200 -26%
TMAM
161
Tokio Marine Asset Management
Japan
$204K -$36.7K -1,500 -15%
IA
162
IFP Advisors
Florida
$195K +$318 +13 +0.3%
FBT
163
First Bank & Trust
South Dakota
$173K -$22.2K -906 -11%
Acadian Asset Management
164
Acadian Asset Management
Massachusetts
$171K +$160K +6,526 +831%
FHA
165
First Horizon Advisors
Tennessee
$145K +$563 +23 +0.4%
PP
166
Paloma Partners
Connecticut
$141K +$147K +6,008 New
AIP
167
Ameritas Investment Partners
Nebraska
$140K
Nisa Investment Advisors
168
Nisa Investment Advisors
Missouri
$138K -$5.38K -220 -4%
Royal Bank of Canada
169
Royal Bank of Canada
Ontario, Canada
$126K -$178K -7,265 -58%
MLICM
170
Metropolitan Life Insurance Company (MetLife)
New York
$120K -$371K -15,170 -75%
CAPTRUST Financial Advisors
171
CAPTRUST Financial Advisors
North Carolina
$94K +$4.53K +185 +5%
SOW
172
State of Wyoming
Wyoming
$91K -$15.7K -640 -14%
PFS
173
Prospera Financial Services
Texas
$49K +$51.4K +2,098 New
US Bancorp
174
US Bancorp
Minnesota
$38K -$10.7K -438 -21%
IRC
175
Investors Research Corp
Georgia
$35K

MD Hedge Fund Activity: Q1 2022 in Review

224 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2022, worth a combined $1.98B — down 13% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new MD positions and 13 closed out — a net gain of 21 holders — while 71 added to existing stakes and 90 trimmed.

The largest buyer was River Road Asset Management, adding an estimated $31.6M. The largest seller was Fidelity Investments, cutting an estimated $50.1M.

  • 224 institutional investors held Pediatrix Medical (MD) as of Q1 2022, up from 204 in Q4 2021.
  • Funds reported $1.98B of Pediatrix Medical stock for Q1 2022, down 13% quarter-over-quarter.
  • 34 funds opened new Pediatrix Medical positions in Q1 2022 and 13 closed out, a net change of +21 holders.
  • The largest Pediatrix Medical buyer in Q1 2022 was River Road Asset Management, an estimated $31.6M added.
  • The largest Pediatrix Medical seller in Q1 2022 was Fidelity Investments, an estimated $50.1M sold.

Based on aggregated 13F filings for Q1 2022.